Drug intelligence / Profile preview

CR-50

Development stage
Preclinical
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
01

Overview

CR-50 is an antibody designed to therapeutically inhibit Reelin, a large extracellular glycoprotein. Reelin plays critical roles in neuronal development and synaptic plasticity in the central nervous system, and also in non-neuronal functions such as promoting endothelial-leukocyte adhesion in inflammation. CR-50 works by interfering with Reelin's homopolymerization and signaling, particularly through its N-terminal region, which is critical for efficient signal transduction and multimer formation. This inhibition aims to reduce inflammation, leukocyte infiltration, and pannus formation in autoimmune diseases, and to modulate neuronal processes in neurological conditions.

Other names
CR-50 antibodyCR50 antibodyCR 50 antibodyanti-Reelin antibody CR-50
02

Targets

RELN (Reelin)

Beyond the preview

Go deeper on CR-50.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CR-50.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call